Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 27 12 2018
accepted: 01 04 2019
pubmed: 30 5 2019
medline: 18 7 2020
entrez: 30 5 2019
Statut: ppublish

Résumé

Axial spondyloarthritides (axSpA) are a group of disorders that share similar pathogenetic mechanisms and clinical picture. The aim of this retrospective multicentric study was to evaluate demographic and clinical differences between ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA) patients. Patients from 7 rheumatological centres in the Lazio region of Italy were included from January 1st, 2010 to April 1st, 2018, if they had undergone pelvic and/or spine radiographs or magnetic resonance imaging (MRI). Images were evaluated by one experienced radiologist in each centre who already had the clinical suspicion of axSpA. Clinical and therapeutic data were collected at the last observation visit. Categorical variables were presented with percentages and analysed by Chi squared test. Continuous variables were expressed as mean ± standard deviation and compared using the parametric unpaired t-test or the non-parametric Mann-Whitney U-test, when appropriate. p-values <0.05 were considered significant. 210 axSpA patients were included: 65.2% with AS and 34.7% with nr-axSpA. When comparing the two groups, AS patients had longer disease duration, were older, were more frequently males, had a greater diagnostic delay and a higher body mass index than the nr-axSpA patients (p<0.0001, p<0.0001, p=0.003 p=0.007, and p=0.04, respectively). The peripheral joints of the nr-axSpA patients were more frequently involved, had higher frequency of inflammatory bowel disease, higher C-reactive protein levels and lower frequency of HLA-B27 positivity (p=0.005, p=0.007, p=0.01, and p=0.01, respectively). TNF inhibitors were used in 87.8% patients with AS and 78.3% with nr-axSpA (p=0.04). More fat metaplasia was observed on MRI in the nr-axSpA group than in the AS group at sacroiliac joints (p=0.003), and more backfills were detected in the AS group on spine-MRI (p=0.003). Spine-bone marrow oedema was more prevalent in AS than in nr-axSpA (p=0.04), and more sclerosis and backfill were found in AS (p=0.003 and p=0.01, respectively). In clinical practice, distinctive features in AS and nr-axSpA patients emerged. Imaging is crucial in guiding the choice of treatment in order to control disease activity and inflammation.

Identifiants

pubmed: 31140397
pii: 13794

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-93

Auteurs

Maria Sole Chimenti (MS)

Rheumatology, Allergology and clinical immunology, University of Rome Tor Vergata, Rome, Italy. maria.sole.chimenti@uniroma2.it.

Paola Conigliaro (P)

Rheumatology, Allergology and clinical immunology, University of Rome Tor Vergata, Rome, Italy.

Luca Navarini (L)

Unit of Allergology, Immunology and Rheumatology, Department of Medicine, Università Campus Bio-Medico di Roma, Italy.

Francesca Maria Martina (FM)

Unità di Diagnostica per Immagini and Dipartimento di Medicina, Università Campus Bio-Medico di Roma, Italy.

Giusy Peluso (G)

Istituto di Reumatologia e Scienze Affini, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Presidio Columbus, Rome, Italy.

Domenico Birra (D)

Istituto di Reumatologia e Scienze Affini, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Presidio Columbus, Rome, Italy.

Paola Sessa (P)

Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.

Michele Anzidei (M)

Radiologia, Dipartimento di Scienze Radiologiche Oncologiche ed Anatomopatologiche, Sapienza Università di Roma, Italy.

Palma Scolieri (P)

UOC Medicina Interna e Reumatologia, Ospedale Nuovo Regina Margherita, Rome, Italy.

Vincenzo Bruzzese (V)

UOC Medicina Interna e Reumatologia, Ospedale Nuovo Regina Margherita, Rome, Italy.

Gianluca Santoboni (G)

UOC Medicina Generale Polo, Ospedale Belcolle, Viterbo, Italy.

Paolo Cardello (P)

UOC Radiologia Diagnostica ed Interventistica, Ospedale Belcolle Viterbo, Italy.

Elisa Gremese (E)

Istituto di Reumatologia e Scienze Affini, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Presidio Columbus, Rome, Italy.

Antonella Afeltra (A)

Unit of Allergology, Immunology and Rheumatology, Department of Medicine, Università Campus Bio-Medico di Roma, Italy.

Guido Valesini (G)

Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.

Gian Domenico Sebastiani (GD)

UO Reumatologia, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.

Roberto Perricone (R)

Rheumatology, Allergology and clinical immunology, University of Rome Tor Vergata, Rome, Italy.

Rossana Scrivo (R)

Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH